Thompson David E. 4
4 · Anthera Pharmaceuticals Inc · Filed May 20, 2013
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2013-05-17+100,000→ 100,000 totalExercise: $0.61Exp: 2023-05-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of May 17, 2013. This stock option is fully exercisable on May 17, 2014.
Signature
/s/ Bradley A. Bugdanowitz, by power of attorney|2013-05-20